Published in J Natl Cancer Inst on November 01, 1979
PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer (PICARES) | NCT03971214
Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst (2013) 3.07
Systemic effects of local radiotherapy. Lancet Oncol (2009) 2.97
Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. Cancer Immunol Res (2014) 2.00
Radiation as an immunological adjuvant: current evidence on dose and fractionation. Front Oncol (2012) 1.76
Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys (2011) 1.60
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ (2013) 1.49
Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer (2011) 1.35
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer (2013) 1.30
Radiation therapy to convert the tumor into an in situ vaccine. Int J Radiat Oncol Biol Phys (2012) 1.19
Role of T lymphocytes in tumor response to radiotherapy. Front Oncol (2012) 1.12
Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol (2010) 1.11
NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy. Front Immunol (2015) 1.11
The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin Dev Immunol (2011) 1.05
Combinations of immunotherapy and radiation in cancer therapy. Front Oncol (2014) 1.01
Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer. Radiat Oncol (2011) 0.98
Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C. Int J Radiat Oncol Biol Phys (2014) 0.93
A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer. Clin Cancer Res (2013) 0.93
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine (2015) 0.92
Emerging Opportunities and Challenges in Cancer Immunotherapy. Clin Cancer Res (2016) 0.89
Radiation and inflammation. Semin Radiat Oncol (2015) 0.86
The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation. Radiat Res (2014) 0.86
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008. Clin Cancer Res (2009) 0.86
Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment. Oncology (Williston Park) (2015) 0.85
Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets. World J Surg Oncol (2015) 0.84
Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice. Cancer Immunol Immunother (2014) 0.83
Radiotherapy: Changing the Game in Immunotherapy. Trends Cancer (2016) 0.80
Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored. Front Immunol (2014) 0.77
Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy. Neuro Oncol (2015) 0.75
Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol (2017) 0.75
EZH2 as a mediator of treatment resistance in melanoma. Pigment Cell Melanoma Res (2016) 0.75
The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications. Sci Immunol (2016) 0.75
A Century of Radiation Therapy and Adaptive Immunity. Front Immunol (2017) 0.75
The changing paradigm of tumour response to irradiation. Br J Radiol (2016) 0.75
Combining radiotherapy with immunotherapy: the past, the present and the future. Br J Radiol (2017) 0.75
Immunotherapy and radiation in glioblastoma. J Neurooncol (2017) 0.75
Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma. Radiother Oncol (2017) 0.75
INTESTINAL OBSTRUCTION : I. A STUDY OF A TOXIC SUBSTANCE PRODUCED IN CLOSED DUODENAL LOOPS. J Exp Med (1913) 16.13
INTESTINAL OBSTRUCTION : III. THE DEFENSIVE MECHANISM OF THE IMMUNIZED ANIMAL AGAINST DUODENAL LOOP POISON. J Exp Med (1914) 5.48
THE SURGICAL TREATMENT OF CHRONIC ULCERATIVE COLITIS. Ann Surg (1923) 4.51
PRESIDENTIAL ADDRESS-DEFENSE OF THE HUMAN BODY AGAINST LIVING MAMMALIAN CELLS. Ann Surg (1942) 3.74
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med (1990) 3.69
VIII. The Experimental Study of Intestinal Obstruction. Ann Surg (1914) 3.59
Large Melena of Obscure Origin. Ann Surg (1944) 3.23
INTESTINAL OBSTRUCTION : IV. THE MECHANISM OF ABSORPTION FROM THE MUCOSA OF CLOSED DUODENAL LOOPS. J Exp Med (1914) 2.80
PILONIDAL SINUS: COCCYGEAL FISTULA. Ann Surg (1924) 2.61
Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys (1995) 2.35
Living Grafts of Endocrine Glands: Part I. Cal West Med (1933) 2.32
RESULTS WITH THE FASCIA PLASTIC OPERATION FOR ANAL INCONTINENCE. Ann Surg (1941) 2.26
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst (1996) 2.19
The influence of fibrin formation on the transplantability of murine tumour cells: implications for the mechanism of the Révész effect. Br J Cancer (1974) 2.12
Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2001) 2.11
Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys (1990) 2.07
Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys (1982) 2.05
Influence of preirradiation of lung on development of artificial pulmonary metastases of fibrosarcoma in mice. Cancer Res (1973) 1.96
Radiation therapy following resection of non-small cell bronchogenic carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.93
A physical concept of soil-water equilibria for nonionic organic compounds. Science (1979) 1.88
THE ACUTE GALL-BLADDER AS A SURGICAL EMERGENCY. Ann Surg (1933) 1.71
Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys (1995) 1.70
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys (1997) 1.70
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Antitumor activity of Corynebacterium parvum. Adv Cancer Res (1978) 1.62
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys (1995) 1.60
Is it time for a new formalism to categorize normal tissue radiation injury? Int J Radiat Oncol Biol Phys (2001) 1.58
Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys. Radiother Oncol (1995) 1.58
What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (1999) 1.55
OPERATIONS FOR DIAPHRAGMATIC HERNIA. Ann Surg (1923) 1.55
Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.53
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res (1998) 1.51
Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50
Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res (1999) 1.48
Quality assurance in a Radiation Oncology Unit: the Chart Round experience. Australas Radiol (2001) 1.45
Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: results of a randomized clinical trial. Cancer J Sci Am (1999) 1.44
Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys (1995) 1.44
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys (1995) 1.40
Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res (1974) 1.39
THE INTERPOSITION OF SMALL BOWEL SEGMENTS BETWEEN DIVIDED ENDS OF THE COLON. Ann Surg (1927) 1.39
Radiation nephropathy in the rhesus monkey: morphometric analysis of glomerular and tubular alterations. Int J Radiat Oncol Biol Phys (1995) 1.37
Positron emission tomography (PET): experience with a large-field-of-view three-dimensional PET scanner. Med J Aust (1999) 1.36
Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer (1994) 1.35
Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys (1997) 1.33
Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer (1995) 1.31
Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst (1987) 1.28
Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys (1990) 1.27
Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res (1997) 1.27
Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys (1983) 1.25
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol (1995) 1.24
Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors. Clin Cancer Res (1999) 1.24
A new isoeffect curve for change in dose per fraction. Radiother Oncol (1983) 1.23
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res (2000) 1.22
Tumor and normal tissue response to metronidazole and irradiation in mice. Radiology (1974) 1.21
IMPERFORATE ANUS WITH RECTOVAGINAL CLOACA. Ann Surg (1936) 1.18
Tissue tolerance to reirradiation. Semin Radiat Oncol (2000) 1.17
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol (1997) 1.17
Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.) Int J Radiat Oncol Biol Phys (2000) 1.16
Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death. Am J Pathol (1986) 1.16
Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. Clin Cancer Res (2000) 1.14
Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon. Br J Cancer (1975) 1.13
Patterns of recurrence in malignant mixed müllerian tumor of the uterus. Cancer (1986) 1.10
Conditioning of tissues for metastasis formation by radiation and cytotoxic drugs. Symp Fundam Cancer Res (1983) 1.10
Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys (1990) 1.10
Inhibition of artificial lung metastases in mice by pre-irradiation of abdomen. Br J Cancer (1980) 1.09
A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour. Br J Cancer (1975) 1.09
Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol (1999) 1.08
The efficacy of postoperative radiotherapy for advanced head and neck cancer: quality of the evidence. Int J Radiat Oncol Biol Phys (1998) 1.07
The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity. Cancer Res (1977) 1.07
TRANSPLANTATION OF LIVING GRAFTS OF THYROID AND PARATHYROID GLANDS. Ann Surg (1934) 1.06
A usability evaluation for telemedicine medical equipment. Telemed J (1999) 1.06
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system. Int J Oncol (2001) 1.05
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. Int J Radiat Oncol Biol Phys (2001) 1.05
Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol (1993) 1.05
SURGICAL TREATMENT OF POST-OPERATIVE SAPHENOUS THROMBOPHLEBITIS. Ann Surg (1932) 1.05
Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res (2000) 1.05
Leg contracture in mice: an assay of normal tissue response. Int J Radiat Oncol Biol Phys (1984) 1.04
Effect of dose-rate on total body irradiation: lethality and pathologic findings. Radiother Oncol (1985) 1.04
Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer (1991) 1.04
Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol (1993) 1.03
Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res (1995) 1.03
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol (2001) 1.03
Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159. Br J Radiol (1976) 1.03
Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res (1994) 1.02
Separation of cells from a murine fibrosarcoma on the basis of size. II. Differential effects of cell size and age on lung retention and colony formation in normal and preconditioned mice. J Natl Cancer Inst (1978) 1.02
Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer (1995) 1.02
Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation. J Med Imaging Radiat Oncol (2008) 1.02
Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading. Cytometry (1985) 1.01
Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys (1994) 1.01
Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. Cancer Res (1987) 1.01
Nasopharyngeal carcinoma in the young: a combined M.D. Anderson and Stanford experience. Int J Radiat Oncol Biol Phys (1990) 1.01
Paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg (1988) 1.00
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. Cancer Res (1994) 1.00
Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair. Br J Cancer Suppl (1984) 1.00
The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys (1990) 0.99
Spontaneous metastasis: random or selective? Clin Exp Metastasis (1986) 0.99
Target cell and mode of radiation injury in rhesus salivary glands. Radiother Oncol (1986) 0.99